Navigation Links
New American Therapeutics Acquires Antiviral Drug Denavir®
Date:10/3/2010

CRANFORD, N.J., Oct. 4 /PRNewswire/ -- New American Therapeutics, Inc., announced today that it acquired all U.S. rights to manufacture, market and sell the antiviral topical drug Denavir® owned by Novartis.  Denavir (1% penciclovir cream) is a highly selective and potent topical antiviral treatment indicated for the treatment of recurrent herpes labialis (cold sores) in adults and children 12 years of age and older.  The topical antiviral cream market in the U.S. is valued at approximately $100 million annually.

Novartis has agreed to provide limited transitional services to New American Therapeutics to allow for a smooth transition of the business to New American Therapeutics.  

"Denavir offers patients a proven therapy for the treatment of herpes labialis.  Likewise, the established revenue stream will provide New American Therapeutics with the capital required to expand our growing infrastructure and product line," stated Alan L. Rubino, CEO and President of New American Therapeutics.  "We are enthusiastic about advancing the commercial efforts of this important asset."

Denavir 1% penciclovir topical cream is a safe and effective medicine when used as directed. Patients should read the package directions before using Denavir.  Possible side effects include headache or irritation at the site of application. Patients should contact their doctor if they experience these symptoms as a result of using Denavir.  Patients should consult their doctor before using 1% penciclovir topical cream if they are allergic to penciclovir or acyclovir (Zovirax®), or any other drugs, or are pregnant or nursing.

About New American Therapeutics, Inc.New American Therapeutics, Inc. is a privately held, specialty pharmaceutical company based in Cranford, N.J. that acquires, markets and develops products in select therapeutic areas.CONTACT:

Alan L. Rubino  908-372-8108Email: arubino@natxcorp.com
'/>"/>

SOURCE New American Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. United American Healthcare Corporation Announces Results of Annual Meeting of Shareholders
2. WellSpring Pharmaceutical, American Gastroenterological Association, and Steven Bramson of Humanscale Partner With MediaPlanet to Publish One of the Largest Digestive Wellness Campaigns in U.S. History to Overcome Upset Stomach, Nausea, IBS, and Deb
3. CVS Caremark Recognizes Its 26,000 Pharmacists During Octobers American Pharmacists Month
4. Idenix Announces Data Presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
5. American College of Surgeons Clinical Congress Convenes in Washington, DC, October 3-7, 2010
6. Millions of Americans Are Living With Hidden Epidemics of Hepatitis B and C, Top Experts Warn
7. Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardiology 2010
8. American Society of Tropical Medicine and Hygiene (ASTMH) Calls for Stronger FDA Science Investment to Better Fight Diseases of Poverty Worldwide
9. Latin American Aortic Stent Graft Market to Reach Over $150 Million by 2015, According to Millennium Research Group
10. American Pacific Adopts Corporate Governance Changes
11. North American Spine Welcomes Kenneth Alo, M.D. to Physician Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... and FAIRFIELD, N.J. , ... and Medimetriks Pharmaceuticals, Inc. (Medimetriks) today announced that they ... development and commercialization rights for OPA-15406 in the U.S. ... also provides manufacturing rights.  OPA-15406 is a topical, non-steroidal ... atopic dermatitis. --> --> ...
(Date:2/8/2016)... -- --> --> ... Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) ... Gynecology) - Global Forecasts to 2020", published by MarketsandMarkets, ... period of 2015 to 2020. The market is expected ... 10.5% from 2015 to 2020. Browse 73 ...
(Date:2/8/2016)... , Feb. 8, 2016 In a historic vote among its ... to construct a medical cannabis cultivation facility and dispensary on tribal land ... New York as a provider for patients in the state,s ... as a provider for patients in the state,s Medical Cannabis ... (34) to approve the project and pursue designation from the ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California and ... pancreatic cancer. , Gary D. Radine, who recently retired as president and CEO of ... Society’s 2015 CEO of the Year , helped lead the effort to raise ...
(Date:2/8/2016)... ... February 08, 2016 , ... Eating disorders and post-traumatic stress ... women and men with eating disorders report a history of trauma, research suggests ... of an eating disorder. , At the 2016 iaedp Symposium, the workshop, ...
(Date:2/8/2016)... ... February 08, 2016 , ... GrassrootsHealth published data from ... type 2 diabetes in the GrassrootsHealth cohort with substantially higher vitamin D levels ... in public health,” states Carole Baggerly, Director of GrassrootsHealth, “the safety and ...
(Date:2/8/2016)... ... February 08, 2016 , ... Joshua ... on how healthcare companies can use newly released government data on populations and ... population and intervene and capture the value they create to succeed in new ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to research ... U.S. require dental technicians to be certified or obtain continuing education. To increase ... the “What’s In Your Mouth?” campaign to inform dentists and patients about the ...
Breaking Medicine News(10 mins):